Celladon Corporation To Present At Barclays Global Healthcare Conference 2014

SAN DIEGO, March 5, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that Krisztina Zsebo, Ph.D., President and Chief Executive Officer, will present a corporate overview at the Barclays Global Healthcare Conference on Wednesday, March 12 at 2:00 p.m. Eastern Time. The conference is being held at the Loews Miami Hotel.

Help employers find you! Check out all the jobs and post your resume.